Navigation Links
Government Must Not Balance Budget on the Backs of the Poor
Date:6/15/2009

ALEXANDRIA, Va., June 15 /PRNewswire-USNewswire/ -- Escalating funding issues challenge social service providers in today's economy. Catholic Charities agencies across the country indicate that decreasing funds impact both those they serve and those they employ. As state governments face new budget years a stark reality has emerged. Proposed and unprecedented cuts to programs that provide minimal, but essential, services to the country's poor and most vulnerable are leaving these people with no hope for safety net services. City, county and state governments are attempting to balance budgets on the backs of those who have the least. As our country strives to recover from this severe economic disaster it must include all Americans in recovery efforts. It is morally imperative that that the country pursue recovery programs and strategies that will not plunge the poor into ever more catastrophic circumstances from which they will find it almost impossible to recover.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081008/CCUSALOGO)

Rev. Larry Snyder, President of Catholic Charities USA, stated, "I call on all government officials at every level to make prudent decisions that will minimize adverse effects on those who have the least in our society." In a public statement issued to elected officials Father Snyder went on to acknowledge that all Americans must share part of the burden of this economic crisis, but the poor and vulnerable must not bare a disproportionate share.

As Catholic Charities agencies in congressional districts across the United States, Guam and Puerto Rico experience unprecedented numbers of people coming to their doors for food, housing, health care and the hope of finding employment the agencies have depleted resourc
'/>"/>

SOURCE Catholic Charities USA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Spains Regional Extremadura Government Launches Electronic Prescription System With IBM
2. In Both the U.S. and Mexico, we Must Advance not Retreat From Strategic Government Goals Regarding Drug Addiction and Drug-Related Crime, Says Narconon International
3. DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm
4. MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage
5. MyOutcomes Urges Government Leaders to Employ Consumer-Driven Outcomes Management in Reforming Behavioral Health System
6. New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction
7. Sanofi Pasteur Receives Order from U.S. Government to Produce New Influenza A(H1N1) Vaccine
8. Government of Canada supports research to improve the health of future generations of Canadians
9. IBM Helps Government of Slovenia to Build Smart Health Insurance System
10. Victory! Colombian Government Cuts Price of Abbotts Lifesaving AIDS Drug Kaletra 55%, Says AHF
11. President of IDF calls for government focus and spending on diabetes and other NCDs
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Negative Pressure Wound Devices Draw FDA Notice, Advice 2Hangovers May Be Tougher for Migraine Sufferers 59737 1Drugs for Irritable Bowel Might Increase Cancer Risk 59736 1Drugs for Irritable Bowel Might Increase Cancer Risk 59736 2Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 1Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 2Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 3